The First Pharma fund focuses on buying, restructuring, and selling pharmacies. It targets operational improvements and sales growth in Portugal.
The First Pharma Fund – Fundo de Capital de Risco Fechado is a non-real estate Collective Investment Scheme focused solely on the pharmacy sector (a stable, essential sector.) , supervised by the Portuguese Regulator, eligible for the Golden Visa Program, that meets the quantitative requirement for investment activity, ensuring entry into the programme and a residence permit in Portugal, as well as visa-free access to Schengen Countries.
The Community Pharmacy sector in Portugal presents a unique and solid investment opportunity, backed by a limited number of licences that guarantee protection and continued appreciation of the investment.
- Minimum Investment: €500,000
- Regulation: CMVM-approved Fund
- Target Sector: Licensed pharmacies
- Fund Duration: 8 years
- Management: Operated by experts in healthcare and Golden Visa compliance
KEY METRICS
- €16M Fund size
- 52% Estimated ROI
- 8 Years Duration
- 20% Hurdle Rate
- 7.84% IRR
- 3.5% Annual Dividends
The fund’s investment portfolio follows a careful purchasing strategy and professionalised operational management aimed at generating capital gains. Backed by a team with experience and a track record in the pharmacy market, First Pharma Fund will operate in a protected, growing and stable market.
Please Note: this is a Private Equity Fund. It is not guaranteed that capital invested will be reimbursed, or that the Fund will distribute returns. All amounts indicated as returns, are potential returns that may or may not be distributed and may vary in accordance with the Fund’s performance.
- Fund Name: First Pharma Fund – Fundo de Capital de Risco Fechado
- Subscription end date: 2027-01-15
- ISIN Code: B-PTSFQGIM0005
- Golden Visa – Yes
- Brochure – Download
